Prostate cancer is discussed at the Cajasol Foundation
“Let life flow” – the motto that gives its name to Prostate Cancer Awareness and Prevention Day, which is being held today at headquarters Cajasol Foundation V Cordoba (Avenida Ronda de los Tejares, 32), organized Reina Sofia University Hospital And Maimonides Institute of Biomedical Research in Cordoba (IMIBIC), in cooperation Cordoba Guadalquivir District And Spanish Association Against Cancer.
Delegate for Health and Consumer Affairs, Bottle of Mary Jesus; representative of the Cajasol Foundation in Cordoba, Juan Manuel Carrasco; Managing Director of the Reina Sofia Hospital, Francisco Trivino; IMIBIK manager, Alvaro Granados; Managing Director of the Cordoba-Guadalquivir District, Javier Fonseca and head of urology service, Pablo Campos. Other city officials were also present at the event.
The main purpose of this meeting is to convey to society the importance of early diagnosis, appreciate teamwork, interdisciplinary and interlevel approach to this pathology, and also explain the directions of research that are being developed. Moderated throughout the day by a communicator Ana Espinoattended by specialists from the Reina Sofia Hospital and IMIBIK: urologist Enrique Gomezradiation oncologist Sonia Garciaoncologist Maria Jose Mendez and researcher Raoul Luquetin addition to Carmen Fernandezpsycho-oncologist AECC.
Teamwork
The incidence of this tumor is more than one hundred cases per 100,000 inhabitants, it mainly affects men aged 45 to 50 years and is currently the second most common cancer among the male population. Prostate cancer has made significant advances in diagnosis and treatment in recent years, with a variety of options available. This makes the approach increasingly complex and requires the recruitment of specialists from different disciplines to ensure that the patient receives the most appropriate care (which mainly includes primary care, urology, medical and radiation oncology, nuclear medicine and pathology).
Radiation oncologist Sonia Garcia He assured that “this interdisciplinary approach is necessary to provide effective, personalized and patient-centered treatment. Collaboration between different specialists improves clinical outcomes and quality of life by ensuring that all aspects of the disease are taken into account globally.”
Urologist Enrique Gomez points out that despite its slow-growing tumor and very high cure rate in most cases, “it continues to be one of the leading causes of cancer death in men.”
Although there are currently no screening treatment protocols, the specialist continues, “new data and advances in diagnostics (with better selection of patients at risk and in need of more invasive testing) put forward the proposal for the creation of a true systematic screening. politicians. “New studies will change clinical practice, as is the case with the PRIME or PROVIDENCE studies, the latter based on the use of artificial intelligence.”
The number of patients with prostate cancer who can be enrolled in medical oncology clinical trials is increasing. In this sense, the doctor Mendez explains that “in recent years we have seen very important progress in the systemic treatment of advanced diseases. “New treatments are being developed that target specific mutations in certain tumors, as well as tumor cell-selective radiopharmaceuticals and immunotherapy agents.”
In its turn, Raoul Luquet spoke about the projects his research group has worked on in recent years, funded by the Carlos III Institute of Health and the Ministry of Science and Innovation, and focusing on the pathological link that exists between obesity and prostate cancer. In particular, the data obtained by his group demonstrate that there are key factors produced and secreted by periprostatic fat (surrounding the prostate) that may play an oncogenic role in the prostate and be associated with the development, progression and aggressiveness of this disease. tumor.
Finally, Carmen Fernandezfrom AECC, emphasized the importance of psychological support for the patient, paying particular attention to the psycho-emotional approach and the most important aspects that work in consultation with men suffering from this disease.
